Spots Global Cancer Trial Database for Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia
Official Title: Primary Imiquimod Treatment Versus Surgery for Vulvar Intraepithelial Neoplasia
Study ID: NCT01861535
Conditions
Study Description
Brief Summary: To evaluate the efficacy (defined as complete clinical response at 6 months) of imiquimod vs. standard treatment (surgery) for vulvar intraepithelial neoplasia (VIN).
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Dep. of Gynecology and Obstetrics, Landes Frauen- und Kinderklinik Linz, Linz, Oberösterreich, Austria
Dep. of Gynecology, Krankenhaus Barmherzige Brüder Graz, Graz, Styria, Austria
Department of Obstetrics and Gynecology/ Medical University of Graz, Graz, , Austria
Department of Gynecology and Obstetrics, Medical University of Innsbruck, Innsbruck, , Austria
Dep. of Gynecology and Obstetrics, Klinikum Klagenfurt, Klagenfurt, , Austria
Dep. of Gynecology and Obstetrics, Leoben, , Austria
Dep. of Gynecology, Krankenhaus Barmherzige Schwestern Linz, Linz, , Austria
Dep. of Gynecology and Obstetrics, Landeskrankenhaus Salzburg, Salzburg, , Austria
Department of General Gynecology and Gynecology Oncology, Medical University of Vienna, Vienna, , Austria
Contact Details
Name: Gerda Trutnovsky, MD
Affiliation: Medical University of Graz
Role: PRINCIPAL_INVESTIGATOR
Name: Karl Tamussino, MD
Affiliation: Medical University of Graz
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
